NCT07063706View on ClinicalTrials.gov

Pharmaceutical Care for Patients Using Capecitabine

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

August 30, 2024

Conditions
Cancer ColorectalCancer GiCapecitabinePharmaceutical ServicesAdverse Drug Reaction (ADR)
Interventions
OTHER

Pharmaceutical Care

Participants in the intervention group received pharmaceutical care

Trial Locations (1)

20231-030

Instituto Nacional de Cancer, Rio de Janeiro

All Listed Sponsors
collaborator

Universidade Federal Fluminense

OTHER

collaborator

Instituto Nacional de Cancer, Brazil

OTHER_GOV

collaborator

Universidade Federal do Rio de Janeiro

OTHER

lead

Faculdade de Farmácia

OTHER